Home
About Us
Company Overview
Board of Directors
Executive Team
Scientific Advisory Board
Corporate Governance
Pipeline
IMX39 Lead Program
Pipeline
Science
The imunexin™ platform
Investors
Why Invest?
Latest News
Financial Reports
Email Alerts
Patients
Partners
Contact
Financial Reports
Investor Documents
15-Apr-2026
Imunexus Therapeutics Limited Half Year Report 31-12-2025
13-Nov-2025
Imunexus Therapeutics Limited Annual Report 30-06-2025
13-Nov-2025
Imunexus Limited Annual Report 30-06-2025
26-May-2025
Imunexus Therapeutics Limited Annual Report 30 June 2024
26-May-2025
Imunexus Limited Annual Report 30 June 2024
30-Jun-2023
Imunexus Therapeutics Limited Annual Report 30 June 2023
30-Jun-2023
Imunexus Limited Annual Report 30 June 2023
30-Jun-2022
Imunexus Therapeutics Limited Annual Report 30 June 2022
30-Jun-2022
Imunexus Limited Annual Report 30 June 2022
9-May-2022
Disclosure of Proxy Votes & Poll Results
9-May-2022
Results of Annual General Meeting
8-Apr-2022
Imunexus Ltd Notice of Meeting AGM
8-Apr-2022
Imunexus Notice of Meeting AGM
30-Jun-2021
Imunexus Therapeutics Limited Annual Report – 30 June 2021
30-Jun-2021
Imunexus Limited Annual Report – 30 June 2021
For more information or investment enquiries, please contact us at
info@imunexus.com